SUMO1/2/3: Products

Small Ubiquitin-like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation. There are four known SUMOs (SUMO1-4). All SUMO proteins share a conserved Ubiquitin domain and a C-terminal diglycine cleavage/attachment site. Following cleavage of a C-terminal prosegment, the C-terminal glycine residue of SUMO is enzymatically attached to a lysine residue on a target protein. In humans, SUMO is conjugated to a variety of molecules in the presence of the SAE1/UBA2 SUMO-activating (E1) enzyme and the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme. In yeast, the SUMO-activating (E1) enzyme is Aos1/Uba2p. SUMOylation can occur without the requirement of a specific SUMO ligase (E3), where SUMO is transferred directly from UBE2I/Ubc9 to specific substrates. Unlike SUMO1, which is usually conjugated to proteins as a monomer, SUMO2 and SUMO3 are known to form high molecular weight polymers on proteins. SUMO precursor processing and deconjugation are catalyzed by a family of cysteine proteases known as SUMO-specific proteases (SENPs) and DeSUMOylating Isopeptidase 1.

Showing 1-2 out of 2 SUMO1/2/3 Products

page of 1
Results Per Page
DescriptionApplicationCat#CitationsImages 

Recombinant Human SUMO Protein Set (1, 2, 3)


Contains 100 ug each of rhSUMO1, rhSUMO2, and rhSUMO3
K-700 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Recombinant Human His6-SUMO Protein Set (1, 2, 3)


Contains 100 ug each of rhHis6-SUMO1, rhHis6-SUMO2, and rhHis6-SUMO3
K-705 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....
page of 1
Results Per Page